FDA clears modules for AI-based CT solution from Siemens Healthineers

Siemens Healthineers announced Thursday, Sept. 26, that it has received FDA clearance for three modules of the company’s AI-Rad Companion Chest CT software. The approvals cover the AI-Rad Companion Engine, Pulmonary and Cardiovascular modules.

This cloud-based solution can assist providers by scanning CT images and identifying potential abnormalities in a patient’s lungs, heart and aorta. The software also automatically completes standardized reports for radiologists to access through their health system’s PACS.

“AI-Rad Companion Chest CT builds on our decades-long expertise in AI and machine learning, digitalizing healthcare and helping providers perform multi-organ image interpretation of the chest with enhanced detection, accuracy, and precision, which can potentially improve outcomes,” David Pacitti, president and head of the Americas at Siemens Healthineers, said in a prepared statement.

AI-Rad Companion Chest CT, according to the statement, has been tested and confirmed with imaging equipment from vendors other than Siemens Healthineers, including GE Healthcare and Philips Healthcare.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.